Skip to main content
search
Conference

ISSX 27th North American Meeting

Conference: ISSX 27th North American Meeting

Date: October 11 - 14, 2026

Location: San Francisco, CA

At the ISSX 27th North American Meeting, themed “Back to the Future: DMPK Foundations and New Concepts,” Certara will showcase how biosimulation and strategic expertise can help drug developers make more confident, model-informed decisions from discovery through clinical development.

Join us at booth #503 or at one of our presentations listed below to connect with our experts and explore solutions for assessing drug-drug interactions, predicting clinical outcomes, and optimizing development strategies:

Presentations

Monday, October 12th | 10:00am - 12:00pm
Symposium 2: Latest advances in assessment of drug-drug interactions
  • Presentation title: PBPK model credibility assessment
  • Speaker: Karen Rowland Yeo, PhD, SVP, Client and Regulatory Strategy, Certara

Posters

Recent Trends in Pharmacokinetic Drug-Drug Interaction Research: A Review of Clinical Data Published in the Literature in 2025

Presenting author: Sophie Argon, PharmD, Senior Scientist, Certara

Pharmacokinetic-Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2025: A Review of Clinical Data Available in New Drug Application Reviews

Presenting author: Jingjing Yu, MD, PhD, Director, Drug Interaction Solutions, Certara

4-Pyridoxic Acid as an Endogenous Biomarker of Renal OAT3 Activity in Pregnancy: Separating Vitamin-B6 Supplementation from Renal Physiology Using NHANES Data and PBPK Modeling

Presenting author: Oliver Hatley, PhD, Senior Principal Scientist, Certara

In Vitro Inhibition of Cytochrome P450 by Glucuronide Metabolites: A Review of the Literature and Recent New Drug Applications

Presenting author: Eva Gil Berglund, PhD, VP, Clinical Pharmacology and Regulatory Strategy, Certara

Meet Us at ISSX 27th North American Meeting (Booth #503)

Request a meeting with our team ahead of the conference.

Whether you’re interested in a software demo or scientific consultation, let us know what you’d like to discuss, and we’ll connect you with the right expert.


Additional Resources

You May Also Like

A glimpse into the future of model-informed drug discovery and development
A glimpse into the future of model-informed drug discovery and developmentPublication

A glimpse into the future of model-informed drug discovery and development

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology
Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in OncologyPublication

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology

The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose
The Road to First-in-Human: Model-Informed Decisions from Discovery to First DoseWebinar

The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose

Fact Sheet

From first-in-human trials to global regulatory approvals and post-launch, Certara solutions can help you move your science forward faster, with confidence.

Download now